Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison
Rheumatology and Therapy · 2026-06 · 13 (3) · 881-884
DOI: 10.1007/s40744-026-00831-8 ↗Kurz gefasst
Korrektur in der Zeitschrift Rheumatology and Therapy, online erschienen am 08.04.2026. Verfasst von Philip J Mease und 8 weiteren Autor:innen. Beteiligte Einrichtung: Swedish Medical Center/Providence St. Joseph Health, and University of Washington, Seattle, WA, USA. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Swedish Medical Center/Providence St. Joseph Health, and University of Washington, Seattle, WA, USA.
- Dermatology Centre, Northern Care Alliance NHS Foundation Trust, The University of Manchester, Manchester Academic Health Science Centre, NIHR Manchester Biomedical Research Centre, Manchester, UK.
- School of Medicine, Griffith University School of Medicine, Brisbane, QLD, Australia.
- University of Rouen, Rouen, France.
- UCB Pharma, Slough, UK.
- UCB Pharma, Brussels, Belgium.
Zitieren
APA
Mease, P. J., Warren, R. B., Nash, P., Grouin, J. M., Lyris, N., Willems, D., Taieb, V., Eells, J., & McInnes, I. B. (2026). Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison. Rheumatology and Therapy, 13(3), 881-884. https://doi.org/10.1007/s40744-026-00831-8
Vancouver
Mease PJ, Warren RB, Nash P, Grouin JM, Lyris N, Willems D, et al. Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison. Rheumatology and Therapy. 2026;13(3):881-884. doi:10.1007/s40744-026-00831-8
BibTeX
@article{Mease2026,
author = {Mease, Philip J and Warren, Richard B and Nash, Peter and Grouin, Jean-Marie and Lyris, Nikos and Willems, Damon and Taieb, Vanessa and Eells, Jason and McInnes, Iain B},
title = {Correction: Comparative Effectiveness of Bimekizumab and Secukinumab in Patients with Psoriatic Arthritis at 52 Weeks Using a Matching-Adjusted Indirect Comparison},
journal = {Rheumatology and Therapy},
year = {2026},
volume = {13},
number = {3},
pages = {881--884},
doi = {10.1007/s40744-026-00831-8}
}
EUVIMED